Femasys Inc FEMY:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:50 AM EDT
1.23quote price arrow up+0.02 (+1.65%)
Volume
39,305
52 week range
0.25 - 4.75
Loading...
  • Open1.24
  • Day High1.25
  • Day Low1.21
  • Prev Close1.21
  • 52 Week High4.75
  • 52 Week High Date10/02/23
  • 52 Week Low0.25
  • 52 Week Low Date09/18/23

Key Stats

  • Market Cap27.331M
  • Shares Out22.22M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta-2.75
  • YTD % Change25.64

KEY STATS

  • Open1.24
  • Day High1.25
  • Day Low1.21
  • Prev Close1.21
  • 52 Week High4.75
  • 52 Week High Date10/02/23
  • 52 Week Low0.25
  • 52 Week Low Date09/18/23
  • Market Cap27.331M
  • Shares Out22.22M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta-2.75
  • YTD % Change25.64

RATIOS/PROFITABILITY

  • EPS (TTM)-0.86
  • P/E (TTM)-1.44
  • Fwd P/E (NTM)-1.74
  • EBITDA (TTM)-14.508M
  • ROE (TTM)-106.57%
  • Revenue (TTM)1.049M
  • Gross Margin (TTM)65.35%
  • Net Margin (TTM)-1,420.27%
  • Debt To Equity (MRQ)44.02%

EVENTS

  • Earnings Date08/10/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Femasys Inc

 

Profile

MORE
Femasys Inc. is a biomedical company. The Company is focused on addressing unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery...
Charles Larsen
Non-Executive Independent Chairman of the Board
Kathy Lee-Sepsick
President, Chief Executive Officer, Director
Daniel Currie
Chief Operating Officer, Senior Vice President
Dov Elefant
Chief Financial Officer
Address
3950 JOHNS CREEK COURT, SUITE 100
Suwanee, GA
30024
United States

Top Peers

SYMBOLLASTCHG%CHG
APRE
Aprea Therapeutics Inc
5.39-0.20-3.58%
CYTH
Cyclo Therapeutics Inc
1.45-0.02-1.36%
RNXT
RenovoRx Inc
1.41-0.04-2.44%
CNTX
Context Therapeutics Inc
1.79-0.08-4.27%
UBX
UNITY Biotechnology Inc
1.58+0.05+3.27%